Home / Biotechnology / Metagenomi

Metagenomics Analysis Market By Product (Kits & Reagents and Data Analytics), By Technology (Function Driven and Sequencing Driven), By Application (Environmental, Human Health and Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

The metagenomics analysis market is expected to grow from US$ 374.6 million in 2017 to US$ 1,505.7 million in 2026, demonstrating rapid growth at a compounded annual growth rate of 16.9% from 2018 to 2026. Increasing demand for microbial screening in the food and chemical industries and a significant increase in the bioinformatics segment drives the metagenomic analysis market's growth.

Market Synopsis

Increasing adoption rates and rising demand from research laboratories for library preparation kits to enhance workflow drive the kits and reagents market's growth.

Kits and reagents are the largest markets in the product segment of the metagenomic analysis market. The key factors consolidating its market growth are the increasing adoption rate and rising demand from research laboratories for library preparation kits to enhance workflow. Data analytics will grow at a steady pace during the forecast period on account of the development of software tools and solutions pertaining to microbiome datasets featuring the latest sequencing technologies and increased compatibility.

The advent of bioinformatics-related solutions and the burgeoning requirement for the development of a genomic data repository consolidates the sequencing-driven market growth.

Sequencing-driven technology is leading the metagenomic analysis market. It is widely adopted for the diagnosis of infectious diseases and the characterization of human gut microbes. The recent advent of bioinformatics-related solutions and increasing demand for the development of genomic data repositories drive the function-driven technology market's growth. Function-driven technology is gaining positive traction in the biotechnology industry for its ability to screen for proteins, vitamins, and antibiotic resistance. This technique is also widely employed in understanding the biodegradation of organophosphorus molecules and estimating their degradation potential.

Environmental applications market growth is being driven by rising demand for screening uncultured microbes and bioremediation.

Environmental applications are reigniting the metagenomics analysis market. Analytical metagenomics studies are widely adopted to understand the impact of anthropogenic activities on the surrounding ecology. The ability to screen uncultured microbes and perform bioremediation drives the environmental application market's growth. Human health applications will register impressive growth in the near future owing to the increasing adoption of metagenomic analysis in epidemiological studies and the high-throughput screening stage of drug discovery and development.

Increasing environmental degradation and rising public health awareness drive market growth in North America.

North America is dominating the regional segment of the metagenomics analysis market with a share of 39%. The major attributes influencing its market growth are rising public health awareness and increasing environmental degradation. The presence of key players such as Agilent Technologies, QIAGEN, Thermo Fisher Scientific, Inc., and others in the North American region supports the growth of the metagenomics analysis market. Europe is the second-largest market, accounting for 26% of the market share, on account of increasing demand for agricultural produce and a significant increase in the research and development sector for the development of biofuel. Asia Pacific holds 17% of the market share owing to rampant growth in the biotechnology industry and proactive government initiatives in developing a bioinformatics framework to concentrate on research activities pertaining to human health.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The following are the market segments for metagenomics analysis:

Biotechnology companies providing metagenomics analysis are Agilent Technologies, Bio-Rad Laboratories, Inc., Illumina, Inc., Luminex Corporation, Novogene Corporation, Promega Corporation, PerkinElmer, Inc., QIAGEN, Takara Bio, Inc., and Thermo Fisher Scientific, Inc.

Key questions are answered in this report.

  • Which biotechnology companies are actively engaged in the metagenomics analysis market?
  • What are the latest technological advancements taking place in the metagenomics analysis market?
  • Which major factors are responsible for the impressive growth of reagents and kits in the products segment?
  • What is the importance of function-driven and sequencing-driven technology in metagenomic analysis?
  • How is metagenomic analysis applied to bioremediation and biofuel generation?
  • Why is North America the leading regional segment in the metagenomics analysis market?

Frequently Asked Questions:

The market for Metagenomics Analysis Market is expected to reach 1,505.7 Mn in 2026.

The Metagenomics Analysis Market is expected to see significant CAGR growth over the coming years, at 16.9%.

The report is forecasted to 2018-2026.

The base year of this report is 2017.

Agilent Technologies, Bio-Rad Laboratories Inc.,Illumina, Inc.,Luminex Corporation,Novogene Corporation are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Mar 2019
Category:  Biotechnology
Report ID:   59618
Report Format:   PDF
Pages:   120
Rating:    4.4 (49)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support